Delivery of Molecules Using Nanoscale Systems for Cancer Treatment and/or Diagnosis
This book focuses on how nanoscale systems can be used to deliver molecules to help with cancer management. It provides a broad overview of some of the key strategies for nanocarrier design. These strategies are brought together by the wide compositional variety of these systems and the diversity of...
Saved in:
| Other Authors: | , |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_97451 | ||
| 005 | 20230220 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20230220s2022 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-0365-4962-0 | ||
| 020 | |a 9783036549613 | ||
| 020 | |a 9783036549620 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-0365-4962-0 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a MMG |2 bicssc | |
| 100 | 1 | |a Franco, Marina Santiago |4 edt | |
| 700 | 1 | |a Youn, Yu Seok |4 edt | |
| 700 | 1 | |a Franco, Marina Santiago |4 oth | |
| 700 | 1 | |a Youn, Yu Seok |4 oth | |
| 245 | 1 | 0 | |a Delivery of Molecules Using Nanoscale Systems for Cancer Treatment and/or Diagnosis |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2022 | ||
| 300 | |a 1 electronic resource (302 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a This book focuses on how nanoscale systems can be used to deliver molecules to help with cancer management. It provides a broad overview of some of the key strategies for nanocarrier design. These strategies are brought together by the wide compositional variety of these systems and the diversity of molecules that may be carried. Additionally, functionalization strategies, codelivery, and combination with other treatment modalities highlight a very active research field. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Pharmacology |2 bicssc | |
| 653 | |a nanostructured lipid carriers | ||
| 653 | |a doxorubicin | ||
| 653 | |a mucositis | ||
| 653 | |a cell internalization | ||
| 653 | |a albumin | ||
| 653 | |a BSA | ||
| 653 | |a CPP | ||
| 653 | |a gold nanorods | ||
| 653 | |a gold nanoprisms | ||
| 653 | |a arginine-rich peptide | ||
| 653 | |a glutathione | ||
| 653 | |a nanoparticles | ||
| 653 | |a oxidative stress | ||
| 653 | |a breast cancer | ||
| 653 | |a gastric cancer | ||
| 653 | |a nanoparticle | ||
| 653 | |a fucoidan | ||
| 653 | |a d-alpha-tocopherylpoly (ethylene glycol) succinate | ||
| 653 | |a combination chemotherapy | ||
| 653 | |a G-quadruplex | ||
| 653 | |a nucleolin | ||
| 653 | |a DNA nanocages | ||
| 653 | |a intracellular localization | ||
| 653 | |a cancer targeting | ||
| 653 | |a molecular dynamics simulations | ||
| 653 | |a mesoporous silica nanoparticles | ||
| 653 | |a radiotherapy | ||
| 653 | |a immunotherapy | ||
| 653 | |a tumor microenvironment | ||
| 653 | |a abscopal effect | ||
| 653 | |a magnetofection in vivo | ||
| 653 | |a magnetic nanoparticles | ||
| 653 | |a iron oxide | ||
| 653 | |a gene delivery | ||
| 653 | |a gene vectors | ||
| 653 | |a codelivery nanocarriers | ||
| 653 | |a photodynamic therapy | ||
| 653 | |a anticancer therapies | ||
| 653 | |a combination therapy | ||
| 653 | |a phthalocyanine | ||
| 653 | |a uterine cervical neoplasms | ||
| 653 | |a photochemotherapy | ||
| 653 | |a in vitro | ||
| 653 | |a in vivo | ||
| 653 | |a nanocarrier | ||
| 653 | |a polyplexes | ||
| 653 | |a siRNA delivery | ||
| 653 | |a glioblastoma therapy | ||
| 653 | |a amphiphilic poly(α)glutamate | ||
| 653 | |a P-selectin | ||
| 653 | |a prodrug | ||
| 653 | |a drug delivery | ||
| 653 | |a targeted therapy | ||
| 653 | |a chemotherapy | ||
| 653 | |a prostate cancer | ||
| 653 | |a prostate-specific membrane antigen | ||
| 653 | |a targeted delivery | ||
| 653 | |a encapsulation | ||
| 653 | |a cabazitaxel | ||
| 653 | |a nanocarriers | ||
| 653 | |a nanosystems | ||
| 653 | |a radiosensitizer | ||
| 653 | |a hypoxia | ||
| 653 | |a synergism | ||
| 653 | |a cancer | ||
| 653 | |a photothermal therapy | ||
| 653 | |a combined antitumor effect | ||
| 653 | |a oxygenation | ||
| 653 | |a hydrogel | ||
| 653 | |a hypoxic tumor | ||
| 653 | |a n/a | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/5975 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/97451 |7 0 |z DOAB: description of the publication |